Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 43 - Drugs for specific purposes, not provided for in groups
Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317)
11/2003
11/05/2003EP1358182A1 Diazocine derivatives and their use as tryptase inhibitors
11/05/2003EP1358181A1 Substituted pyrrolidines as ccr-3 receptor antagonists
11/05/2003EP1358180A2 Naphthostyril derivatives and their use as inhibitors of cyclin-dependent kinases
11/05/2003EP1358178A2 Sulfonamide lactam inhibitors of factor xa
11/05/2003EP1358177A2 Treatment of affective disorders by the combined action of a nicotinic receptor agonist and a monoaminergic substance
11/05/2003EP1358175A2 Phenoxy substituted benzocondensed heteroaryl derivatives as thyroid receptor ligands
11/05/2003EP1358174A2 Inhibitors of cruzipain and other cysteine proteases
11/05/2003EP1358172A2 Amino ceramide-like compounds and therapeutic methods of use
11/05/2003EP1358168A1 Tricyclic lactam and sultam derivatives and their use as histone deacetylase inhibitors
11/05/2003EP1358165A1 Imidazole derivatives
11/05/2003EP1358162A1 Dihydroindole and tetrahydroquinoline derivatives
11/05/2003EP1358161A2 N-pyridyl carboxamide derivatives and pharmaceutical compositions containing them
11/05/2003EP1358157A1 Carbazole derivatives and their use as neuropeptide y5 receptor ligands
11/05/2003EP1358156A2 Benz(g) indoles and their use as spla2 inhibitors
11/05/2003EP1358154A2 Pyrrolidine derivatives, their preparation and their use as inhibitors of neuraminidases
11/05/2003EP1358153A1 Ophthalmic compositions for treating ocular hypertension
11/05/2003EP1357977A2 Chromium containing compositions for the treatment of diabetes, the reduction of body fat, improvement of insulin sensitivity and reduction of hyperglycemia and hypercholesteremia
11/05/2003EP1357974A1 Novel compositions of potassium channel openers and protein kinase c inhibitors and use thereof
11/05/2003EP1357955A1 Drug delivery from stents
11/05/2003EP1357930A2 Histidine-rich glycoprotein
11/05/2003EP1357929A2 Modulation of immune response and methods based thereon
11/05/2003EP1357915A2 PHARMACEUTICAL FORMULATION COMPRISING PYRAZOLO 4,3-d]PYRIMIDINES AND ENDOTHELIN RECEPTOR ANTAGONISTS OR THIENOPYRIMIDINES AND ENDOTHELIN RECEPTOR ANTAGONISTS
11/05/2003EP1357913A1 Heterocyclic inhibitors of glycine transporter 2
11/05/2003EP1357909A1 Il-8 receptor antagonists
11/05/2003EP1357908A2 Acyl sulfamides for treatment of obesity, diabetes and lipid disorders
11/05/2003EP1357906A2 Blockade of sodium channels by phenol derivatives
11/05/2003EP1357903A2 STABILIZED FORMULATIONS OF 6-HYDROXY-3-(4- 2-(PIPERIDIN-1-YL) ETHOXY]PHENOXY)-2-(4-METHOXYPHENYL) BENZO b]THIOPHENE AND SALTS THEREOF
11/05/2003EP1357881A2 Inhibitors of spermidine synthase for the treatment of osteoarthritis and cartilage rehabilitation
11/05/2003EP1357855A2 Ophthalmic compositions for treating ocular hypertension
11/05/2003EP1357811A1 Composition and method for smoke detoxification
11/05/2003EP1220858B1 Oxazinoquinolones useful for the treatment of viral infections
11/05/2003EP1212300B1 Azacycloalkanone serine protease inhibitors
11/05/2003EP1178960B1 Vitamin d analogues and their pharmaceutical use
11/05/2003EP1107973B1 NOVEL THIENO[2,3-d]PYRIMIDINEDIONES, PROCESS FOR THEIR PREPARATION AND USE THEREOF IN THERAPY
11/05/2003EP1105141B1 Phosphatidylcholine as a medicament for the protection of mucosa
11/05/2003EP1082298B1 1-alpha-HYDROXY-25-ENE-VITAMIN D, ANALOGS AND USES THEREOF
11/05/2003EP1068194B1 Pde iv inhibiting pyridine derivatives
11/05/2003EP1054857B1 Biaryl-acetic acid derivatives and their use as cox-2 inhibitors
11/05/2003EP1019047B1 Antithrombotic agents
11/05/2003EP1007034B1 Compositions containing bergamottin for increasing the oral bioavailability of pharmaceutical agents
11/05/2003EP0989985B1 Fused polycyclic 2-aminopyrimidine derivatives as protein kinase inhibitors
11/05/2003EP0975617B1 Inhibitors of cholesterol esterase
11/05/2003EP0956854B1 Pharmaceutical composition comprising coenzyme q 10
11/05/2003EP0946566B1 Pro-drugs and counterparts of camptothecin, their application as medicines
11/05/2003EP0814847B1 Methods and compositions for in-vivo detection of oral cancers and precancerous conditions
11/05/2003EP0713495B1 Methods of enhancing bioactivity of chemokines
11/05/2003EP0652874B1 2-heterocyclic-5-hydroxy-1,3-pyrimidines useful as antiinflammatory agents
11/05/2003EP0651801B1 Polypeptides having serotoninergique activity (5ht5a), nucleic acids coding for these polypeptides and uses thereof
11/05/2003EP0489058B1 Cystic fibrosis gene
11/05/2003CN1454264A The method of detecting mutant DSPP gene of hereditary opalescent dentin
11/05/2003CN1454256A The high bone mass gene of 11q13.3
11/05/2003CN1454213A Variants of allergenic proteins of the Group2 of dermatophagoides
11/05/2003CN1454211A Nitrogen containing heterobicycles as factor xa inhibitors
11/05/2003CN1454210A 嘧啶衍生物 Pyrimidine derivatives
11/05/2003CN1454209A 1-benzyl-4-[(5, 6-dimethoxy-2-fluoro-1-indanon)-2-yl] methylpiperidine
11/05/2003CN1454203A Substituted nitrated catechols their use in the treatment of some central and peripheral nervous system disorders and pharmaceutical compositions containing them
11/05/2003CN1454097A Polymer-modified synthetic proteins
11/05/2003CN1454092A Use of bioactive fraction from cow urine distillate (ÔÇÿGo-mutraÔÇÖ) as a bio-enhancer of anti-infective, anti-cancer agents and nutrients
11/05/2003CN1454087A The use of scopolamine salts
11/05/2003CN1453013A Chinese medicine for health of driver
11/05/2003CN1453009A Raw rhubarb powder injection and its prepn
11/05/2003CN1452994A Multifunctional paster
11/05/2003CN1126816C Method for large scale production of recombined-adenovirus accompanying virus and application thereof
11/05/2003CN1126759C Oligopeptide compounds containing D-2-alkyltryptophan capable of promoting release of growth hormone
11/05/2003CN1126743C Substituted quinazoline derivatives
11/05/2003CN1126737C Novel pyrrole compound, its preparation and pharmaceutical composition containing the same
11/05/2003CN1126567C Stalilized composition for NGF and reagent box and preparing process thereof
11/05/2003CN1126558C Medicine for treating kidney damage caused by immunological disease lupus erythematosus
11/05/2003CN1126555C Chinese medicine for promoting height and growing intelligence
11/05/2003CN1126552C Marine biological selenium products and preparing process thereof
11/05/2003CN1126543C Pharmaceutical composition for oral administration of N-piperidino-3-phrazolecarboxamide derivative, its salts and their solvates
11/04/2003US6642410 Useful as antiproliferative agents, including, for example, anticancer agents
11/04/2003US6642389 Oxazole derivatives
11/04/2003US6642381 Pyrimido[5,4-e][1,2,4]triazine-5,7-diamine compounds as protein tyrosine phosphatase inhibitors
11/04/2003US6642368 Programmed cell death and caspase-12
11/04/2003US6642363 Bonded to a peptide which promotes cell adhesion and growth; use in drug delivery, cell transplantation and tissue engineering
11/04/2003US6642362 Genes coding proteins for early liver development and their use in diagnosing and treating liver disease
11/04/2003US6642358 Receptor that binds trail
11/04/2003US6642267 Side effect reduction over opioid analgesics; analgesic and/or anxiolytic action
11/04/2003US6642266 EP4 receptor selective agonists in the treatment of osteoporosis
11/04/2003US6642264 Thiazolobenzoimidazole derivatives
11/04/2003US6642256 Brain disorders, psychological disorders, antiischemic agents, central nervous system disorders
11/04/2003US6642252 Anticoagulants in treating and preventing cardiovascular diseases, as anti-inflammatory agents, and as metastasis inhibitors in treating cancer.
11/04/2003US6642251 Antitumor, 2-indolinone derivatives
11/04/2003US6642250 1,8-naphthyridin-2(1H)-one derivatives
11/04/2003US6642247 Treting anxiety, stress, depression, trauma, Alzheimer's mediated memory loss, epilepsy, arterial blood pressure disorders, obesity, acute pain, chronic pain, Na+ excretion, control of water balance, and symptoms associated with drug
11/04/2003US6642241 Alkylamino- substituted dihydropyrimido-(4,5-d)pyrimidinone derivatives, inhibitors of p38,
11/04/2003US6642239 Dipeptide nitrile cathepsin K inhibitors
11/04/2003US6642237 Inhibitors of HIV protease and inhibitors of HIV replication, used in the prevention or treatment of infection by HIV and treatment for AIDS
11/04/2003US6642235 Administering a therapeutically effective amount of a formulation comprising compound having a pharmacological selectivity of serotonin (Ki)/norepinephrine (Ki) of 5000; for selectively inhibiting reuptake of norepinephrine
11/04/2003US6642233 Strong affinity and high selectivity for the human NK1 receptors of substance P.
11/04/2003US6642232 3-[4-Substituted heterocyclyl)-pyrrol-2-ylmethylidene]-2- indolinone derivatives as kinase inhibitors
11/04/2003US6642230 Imidazopyrimidines and imidazopyridines for the treatment of neurological disorders
11/04/2003US6642229 3-Phenyl-imidazo-pyrimidine derivatives as ligands for GABA receptors
11/04/2003US6642228 α1b-adrenergic receptor antagonists
11/04/2003US6642227 Such as 2-methylsulfanyl-5-(2-phenylamino-pyrimidin-4-yl)-4-p-tolyl-thiophene-3 -carbonitrile; antiproliferative agents; stents
11/04/2003US6642226 Such as cis-(3,5-bis-trifluoromethyl-phenyl)-(4-(4-methyl-piperazin-1-yl),-3-phenyl -piperidin-1-yl)-methanone; for treatment of diseases related to neurokinin receptors
11/04/2003US6642225 Diazacycloalkanedione derivatives
11/04/2003US6642223 Benzoheterocyclic derivatives
11/04/2003US6642214 Oligomer consisting of two cyclodextrin molecules joined by bifunctional spacer, optionally having affinity group which interacts with molecular target structure; physical inclusion complex formed with drug reduces side effects
1 ... 699 700 701 702 703 704 705 706 707 708 709 710 711 712 713 714 715 716 717 718 719 ... 1564